A DLL3-targeted antibody-drug conjugate eradicates high-grade pulmonary neuroendocrine tumor-initiating cells in vivo.Saunders LR, Bankovich AJ, Anderson WC, Aujay MA, Bheddah S, Black K, Desai R, Escarpe PA, Hampl J, Laysang A, Liu D, Lopez-Molina J, Milton M, Park A, Pysz MA, Shao H, Slingerland B, Torgov M, Williams SA, Foord O, Howard P, Jassem J, Badzio A, Czapiewski P, Harpole DH, Dowlati A, Massion PP, Travis WD, Pietanza MC, Poirier JT, Rudin CM, Stull RA, Dylla SJ
(2015)
Sci Transl Med 7: 302ra136
MeSH Terms: Animals, Antibodies, Monoclonal, Antineoplastic Agents, Female, Humans, Immunoconjugates, Intracellular Signaling Peptides and Proteins, Lung Neoplasms, Membrane Proteins, Mice, Mice, Inbred NOD, Mice, SCID, Neuroendocrine Tumors, Xenograft Model Antitumor AssaysAdded February 16, 2016